Filing Details
- Accession Number:
- 0001209191-10-018094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-22 13:00:00
- Reporting Period:
- 2010-03-18
- Filing Date:
- 2010-03-22
- Accepted Time:
- 2010-03-22 06:04:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380762 | Brian Dorsey | C/O Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130 | Vp Product Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-03-18 | 5,580 | $3.94 | 21,920 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2010-03-18 | 8,100 | $6.61 | 13,820 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-18 | 2,100 | $7.89 | 11,720 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-18 | 1,800 | $8.91 | 9,920 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-18 | 500 | $9.75 | 9,420 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-03-18 | 25,542 | $1.23 | 34,962 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-03-18 | 32,458 | $1.23 | 67,420 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-18 | 23,000 | $5.23 | 44,420 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-18 | 15,800 | $6.67 | 28,620 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-18 | 15,900 | $7.92 | 12,720 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-18 | 2,800 | $8.78 | 9,920 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-18 | 500 | $9.74 | 9,420 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-03-18 | 25,542 | $0.00 | 25,542 | $1.23 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-03-18 | 32,458 | $0.00 | 32,458 | $1.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,839 | 2018-02-18 | No | 4 | M | Direct | |
| 50,875 | 2019-02-16 | No | 4 | M | Direct |
Footnotes
- Pursuant to the terms of a Restricted Stock Award Agreement dated as of October 8, 2007 between the reporting person and the issuer, the reporting person is transferring the shares to the issuer to meet the reporting person's obligation to pay to the issuer the tax that the issuer is required to withhold in connection with the vesting of 15,000 shares of restricted stock.
- This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, with the proceeds remitted to the Company to cover the taxes withheld upon the vesting of 15,000 restricted stock units on March 18, 2010.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.24 to $7.23 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.35 to $8.21 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.47 to $9.30 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.61 to $9.84 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 trading plan adopted by the reporting person in 2009.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $5.10 to $5.29 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.24 to $7.24 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.31 to $8.17 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.39 to $9.2256 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- 1/3 of the shares of Common Stock subject to this grant vested on the date of grant (June 9, 2009) and the remaining shaes will vest and become exercisable in 24 equal monthly installments over the following two-year period.
- Not applicable.
Billionaire Hedge Funds
